{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-001085","form_type":"8-K","ticker":"CCCC","cik":"0001662579","company_name":"C4 Therapeutics, Inc.","filed_at":"2024-01-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.021725+00:00","generated_at":"2026-06-07T00:34:44.517718+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"medium","headline":"C4 Therapeutics posts investor presentation; announces restructuring to preserve cash runway into 2027","bullets":["Company posted investor presentation on January 11, 2024, detailing a restructuring plan.","Restructuring expected to preserve cash runway into 2027.","Estimated charges and costs for restructuring to be incurred in connection with cost-saving initiatives.","Forward-looking statements include expectations on timing, costs, and efficiencies from the restructuring."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-001085","json":"https://secwatch.observer/filing/0001628280-24-001085.json","markdown":"https://secwatch.observer/filing/0001628280-24-001085.md","text":"https://secwatch.observer/filing/0001628280-24-001085.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1662579/000162828024001085/0001628280-24-001085-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1662579/000162828024001085/cccc-20240111.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T00:34:44.517718+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}